OncoSec Medical, Inc.
(NASDAQ : ONCS)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Services » Medical Or Nursing Services
symbolcompany%chnglast%shortavg$volume
SDCSmileDirectClub, Inc. 18.55%7.110.0%$100.06m
GHGuardant Health, Inc. 2.12%129.670.0%$96.68m
OPCHOption Care Health, Inc. 0.47%25.670.0%$87.30m
NVTAInvitae Corp. 1.65%30.231.1%$84.23m
CANOCano Health, Inc. -2.27%15.090.0%$71.79m
OSHOak Street Health, Inc. 2.92%53.250.0%$71.14m
NTRANatera, Inc. 0.65%121.151.1%$66.57m
DVADaVita, Inc. 0.03%121.293.7%$62.13m
AMEDAmedisys, Inc. 1.43%171.4411.4%$53.58m
FLGTFulgent Genetics, Inc. 3.43%89.040.6%$43.03m
CHEChemed Corp. -0.04%477.9010.2%$37.85m
ONEM1Life Healthcare, Inc. 3.61%24.570.0%$35.57m
NEONeoGenomics, Inc. 0.78%47.755.1%$34.09m
LHCGLHC Group, Inc. 0.25%166.002.9%$33.23m
ACHCAcadia Healthcare Co., Inc. 2.02%60.5626.8%$23.98m

Company Profile

OncoSec Medical, Inc. is a biotechnology company focused on designing, developing and commercializing therapies and proprietary medical approaches to stimulate and to guide an anti-tumor immune response for the treatment of cancer. Its lead product candidate, ImmunoPulse IL-12, uses an electroporation device, with the aim of reversing the immunosuppressive microenvironment in the treated tumor. The company was founded by Avtar S. Dhillon and Punit S. Dhillon on February 8, 2008 and is headquartered inPennington, NJ.